Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma.

Neupogen (filgrastim) - Kyowa Kirin, Amgen

isotretinoin - Generic mfg.

Imunace (teceleukin) - Shionogi

Leukine (sargramostim) - Partner Therap

Unituxin (dinutuximab) - United Therapeutics Corporation, Ohara Pharma

Proleukin (aldesleukin) - Iovance Biotherap

http://www.ncbi.nlm.nih.gov/pubmed/42490004

Akinobu Hamada; Chika Nitani; Hiroshi Kawamoto; Junichi Hara; Kenichi Yoshimura; Kimikazu Matsumoto; Kiyoshi Yoshimura; Shuhei Karakawa; Tomoaki Taguchi; Toshimi Kimura; Yuki Yuza

Jul 24, 2026